LADICEF

This brand name is authorized in Nigeria.

Active ingredients

The drug LADICEF contains one active pharmaceutical ingredient (API):

1	Ceftriaxone UNII 023Z5BR09K - CEFTRIAXONE SODIUM
	Ceftriaxone is an antibacterial for systemic use, a third-generation cephalosporin. It inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs) leading to bacterial cell lysis and death.
	Read more about Ceftriaxone

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-7287	Injection	Ladicef Injection INJ 1 g 1 x 1 vial + 10 mL sterile water for injection (in ampoule)	Powder for Injection 50 CMS-PP-340599 LADICEF INJECTION CEFTRIAXONE SODIUM 1G Ceftriaxone Sodium equivelent to 1g Ceftriaxione A4-7287 Drugs Imported Products 1 vial +10ml ampoule SWFI Prescription Only Medicine (POM) 7/29/2023 LADFIELD GLOBAL RESOURCES LIMITED, 335 IGBEDE ROAD, AJANGBADI, OJO LAGOS. 8023078302 royelad@yahoo.com SHANDONG XIER KANGTAI PHARMACEUTICAL CO. , LTD., PRIVATE ECONOMY GARDEN, XINYAN TOWN, YANZHOU, JINING CITY, SHANDONG. CHINA., China	28/09/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DD04	Ceftriaxone	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-7287